Table 3.

Models of co-operation in multidisciplinary cancer care

	1. Advisory committee	2. Formal co-adaptation	3. Integrated care process
Cases submitted (approx. %)	"Complex" cases or off-protocol: 10% - 50%	All "possible" cases: 50% - 80%	Initial source of clinical assessment: 90%-100%
Patient access to team	Treatment (whether or not initiated)	Diagnosis or treatment	Suspect or diagnosis (early access)
Nature of agreements	Recommendations	Consensus decisions not always implemented	Binding decisions defended by the team
Professional team roles	Negative perception	Chair, tumour board co-ordinator	Chair, co-ordinator, nurse case manager
Impact on clinical process management	Minor changes	Some segments of care	Whole process (cross-boundary frequent)
Specialist participation	No diagnostic specialisations	Absences due only to timetable problems	Professionals associated with a clinical committee
Junior doctors and nursing role, in terms of attendance	Considered inappropriate	Open meeting, participation encouraged	Mandatory presence
Hospital executive board role	Lack of interest	Acknowledgement without express support	Express support (room, clerk, etc.)
Presence in health system	40%	50%	10%